GP5d
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1235)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep quantitative phosphoproteome analysis., Omics: Deep exome analysis., Omics: CRISPR phenotypic screen., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7601566
PMID:10051639
PMID:10737795
PMID:20215515
PMID:20570890
PMID:20606684
PMID:24755471
PMID:25485619
PMID:25877200
PMID:25926053
PMID:25944804
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28854368
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
Gp5d, Gp5D, GP5D |
|
|
CLO:CLO_0003555,
EFO:EFO_0006576,
CLDB:cl1512,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:877,
BioSample:SAMN03472981,
cancercelllines:CVCL_1235,
Cell_Model_Passport:SIDM00537,
ChEMBL-Cells:CHEMBL3308735,
ChEMBL-Targets:CHEMBL1075450,
ColonAtlas:GP5d,
Cosmic:907291,
Cosmic:995384,
Cosmic:1043811,
Cosmic:1479572,
Cosmic:1609497,
Cosmic:1803941,
Cosmic:2301974,
Cosmic:2800587,
Cosmic-CLP:907291,
DepMap:ACH-001345,
ECACC:95090715,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907291,
GEO:GSM827313,
GEO:GSM1346871,
GEO:GSM1448106,
GEO:GSM1669814,
IARC_TP53:21348,
LINCS_LDP:LCL-1176,
PharmacoDB:GP5d_411_2019,
PRIDE:PXD005235,
PRIDE:PXD030304,
Progenetix:CVCL_1235,
PubChem_Cell_line:CVCL_1235,
Wikidata:Q54871634 |
|
|
CVCL_1235 |
2025-01-31 12:12:25 |
2 |
GR-M
Resource Report
Resource Website
Contaminated
|
(RRID:CVCL_2451)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: SNP array analysis., Omics: Deep exome analysis., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a PSN1 derivative (PubMed=25877200). Originally thought to originate from the chest of a 36 year old male melanoma patient with skin metastases..
|
PMID:7780963
PMID:15592718
PMID:23851445
PMID:25485619
PMID:25877200
PMID:26589293
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
GRM |
|
|
CLO:CLO_0003564,
EFO:EFO_0006577,
CLDB:cl1513,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03472907,
BioSample:SAMN10988055,
cancercelllines:CVCL_2451,
Cell_Model_Passport:SIDM00468,
Cosmic:2163785,
DepMap:ACH-001072,
ECACC:95032301,
EGA:EGAS00001000610,
ESTDAB:ESTDAB-036,
IARC_TP53:21349,
PharmacoDB:GRM_412_2019,
Progenetix:CVCL_2451,
Wikidata:Q54871656 |
|
|
CVCL_2451 |
2025-01-31 12:12:26 |
0 |
GOS-3
Resource Report
Resource Website
1+ mentions
Contaminated
|
(RRID:CVCL_2050)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Deep exome analysis., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a U-343MGa derivative (PubMed=22570425). Originally thought to originate from the brain of a 55 year old patient with a mixed astro-oligodendroglioma (grade II/III)..
|
PMID:9760066
PMID:22460905
PMID:22570425
PMID:25877200
PMID:26589293
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
GOS 3, GOS3 |
|
|
CLO:CLO_0003550,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN03151979,
BioSample:SAMN03470943,
BioSample:SAMN10987798,
cancercelllines:CVCL_2050,
CCRID:1101HUM-PUMC000467,
Cell_Model_Passport:SIDM01635,
DepMap:ACH-000027,
DSMZ:ACC-408,
DSMZCellDive:ACC-408,
GEO:GSM887026,
GEO:GSM888096,
IARC_TP53:21347,
LiGeA:CCLE_213,
LINCS_LDP:LCL-1406,
PharmacoDB:GOS3_408_2019,
Progenetix:CVCL_2050,
Wikidata:Q54871613 |
|
|
CVCL_2050 |
2025-01-31 12:12:24 |
3 |
GTL-16
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_7668)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Deep exome analysis., Characteristics: MET is amplified and overexpressed in this cell line., Population: Japanese.
|
PMID:1486568
PMID:1674365
PMID:2541345
PMID:22745804
PMID:24807215
PMID:25485619
PMID:26589293
|
Cancer cell line
|
Female |
GTL 16, GTL16 |
|
|
EFO:EFO_0006578,
ArrayExpress:E-MTAB-2706,
cancercelllines:CVCL_7668,
ChEMBL-Cells:CHEMBL3308698,
ChEMBL-Targets:CHEMBL612708,
Cosmic:755306,
Cosmic:755613,
Cosmic:887246,
Cosmic:1945868,
Cosmic:2069777,
Cosmic:2484973,
Cosmic:2807624,
EGA:EGAS00001000610,
GEO:GSM685812,
GEO:GSM686033,
GEO:GSM686034,
GEO:GSM843505,
GEO:GSM1178098,
GEO:GSM1178099,
GEO:GSM1374485,
GEO:GSM1374486,
PharmacoDB:GTL16_418_2019,
Progenetix:CVCL_7668,
PubChem_Cell_line:CVCL_7668,
Wikidata:Q54871835 |
|
|
CVCL_7668 |
2025-01-31 12:12:33 |
3 |
H4
Resource Report
Resource Website
10+ mentions
|
(RRID:CVCL_1239)
|
|
|
Miscellaneous: Originally classified as originating from a neuroglioma, an obsolete classification. This cell line has been reclassified as an astrocytoma., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:4544026
PMID:6256643
PMID:6500159
PMID:10074188
PMID:10560660
PMID:11414198
PMID:11508811
PMID:19435942
PMID:20164919
PMID:20215515
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Male |
H-4 |
|
|
BTO:BTO_0003704,
CLO:CLO_0003599,
EFO:EFO_0002184,
CLDB:cl5193,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-148,
BCRJ:0263,
BioGRID_ORCS_Cell_line:430,
BioSample:SAMN03472722,
BioSample:SAMN10987915,
cancercelllines:CVCL_1239,
CCRID:1101HUM-PUMC000372,
CCRID:4201HUM-CCTCC00128,
CCTCC:GDC0128,
Cell_Model_Passport:SIDM00852,
ChEMBL-Cells:CHEMBL3308507,
ChEMBL-Targets:CHEMBL1075452,
CLS:300184,
Cosmic:687571,
Cosmic:849856,
Cosmic:907042,
Cosmic:1610749,
Cosmic:1746955,
Cosmic:2060805,
Cosmic:2302320,
Cosmic:2367529,
Cosmic-CLP:907042,
DepMap:ACH-000389,
EGA:EGAS00001000978,
ENCODE:ENCBS381KGR,
ENCODE:ENCBS836LDB,
ENCODE:ENCBS902ISQ,
GDSC:907042,
GEO:GSM326236,
GEO:GSM887031,
GEO:GSM888101,
GEO:GSM1669834,
IARC_TP53:21355,
IGRhCellID:H4,
IZSLER:BS TCL 102,
KCB:KCB 2012027YJ,
LiGeA:CCLE_383,
LINCS_LDP:LCL-1401,
Lonza:285,
PharmacoDB:H4_437_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1239,
PubChem_Cell_line:CVCL_1239,
TOKU-E:1367,
Wikidata:Q54872126 |
|
|
CVCL_1239 |
2025-01-31 12:12:45 |
27 |
Farage
Resource Report
Resource Website
1+ mentions
|
(CLS Cat# 305071, RRID:CVCL_3302)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9172815
PMID:11378582
PMID:19278952
PMID:19358282
PMID:20215515
PMID:20628145
PMID:23292937
PMID:25485619
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
FARAGE, Farage OL, Farage Original Line |
CLS |
305071 |
CLO:CLO_0002997,
EFO:EFO_0006393,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2630,
BioSample:SAMN03471757,
cancercelllines:CVCL_3302,
CCRID:4201HUM-CCTCC00319,
CCTCC:GDC0319,
Cell_Model_Passport:SIDM00859,
ChEMBL-Cells:CHEMBL4483171,
ChEMBL-Targets:CHEMBL4483236,
CLS:305071,
Cosmic:1295510,
Cosmic:1517602,
Cosmic:1541919,
Cosmic:1945180,
Cosmic:2022591,
Cosmic:2276315,
Cosmic-CLP:1297449,
DepMap:ACH-001498,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1297449,
GEO:GSM380125,
GEO:GSM552429,
GEO:GSM907525,
GEO:GSM1035331,
GEO:GSM1374481,
GEO:GSM1669792,
IGRhCellID:Farage,
LINCS_LDP:LCL-1131,
PharmacoDB:Farage_366_2019,
PRIDE:PXD028647,
PRIDE:PXD030304,
Progenetix:CVCL_3302,
PubChem_Cell_line:CVCL_3302,
Wikidata:Q54833249 |
|
|
CVCL_3302 |
2025-01-31 12:03:03 |
4 |
Hep-G2/C3A
Resource Report
Resource Website
100+ mentions
|
(RRID:CVCL_1098)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep exome analysis., Virology: Susceptible to infection by Zika virus (ZIKV) (PubMed=29468137)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:12068308
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:29468137
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
HepG2/C3A, Hep G2/C3A, C3A |
|
|
BTO:BTO_0003586,
CLO:CLO_0002119,
EFO:EFO_0002121,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-3581,
ATCC:CRL-10741,
BCRC:60177,
BCRJ:0291,
BioSample:SAMN03473207,
BioSample:SAMN10987645,
cancercelllines:CVCL_1098,
Cell_Model_Passport:SIDM01237,
ChEMBL-Cells:CHEMBL3308377,
ChEMBL-Targets:CHEMBL1075402,
Cosmic:724820,
Cosmic:910850,
Cosmic:1995354,
Cosmic-CLP:910850,
DepMap:ACH-001021,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FCS-free:10-2-11-3-4-4,
GDSC:910850,
GEO:GSM886899,
GEO:GSM887964,
GEO:GSM1669638,
IARC_TP53:21205,
IARC_TP53:27688,
IGRhCellID:C3A,
LINCS_LDP:LCL-1927,
PharmacoDB:C3A_156_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1098,
PubChem_Cell_line:CVCL_1098,
Ubigene:YC-C093,
Wikidata:Q54882789 |
|
|
CVCL_1098 |
2025-01-31 12:16:27 |
119 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
|
|
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(AddexBio Cat# C0050001/4983, RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
AddexBio |
C0050001/4983 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(NCBI_Iran Cat# C144, RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
NCBI_Iran |
C144 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(TKG Cat# TKG 0403, RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
TKG |
TKG 0403 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
Hep-G2
Resource Report
Resource Website
10000+ mentions
Misclassified
Misclassified
Discontinued
Discontinued
|
(RRID:CVCL_0027)
|
|
|
Omics: Virome analysis using proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Secretome proteome analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: miRNA expression profiling., Omics: Metabolome analysis., Omics: Genome sequenced., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep proteome analysis., Omics: Deep phosphoproteome analysis., Omics: Deep exome analysis., Omics: Deep antibody staining analysis., Omics: H4K20me1 ChIP-seq epigenome analysis., Omics: H3K9me3 ChIP-seq epigenome analysis., Omics: H3K9ac ChIP-seq epigenome analysis., Omics: H3K79me2 ChIP-seq epigenome analysis., Omics: H3K4me3 ChIP-seq epigenome analysis., Omics: H3K4me2 ChIP-seq epigenome analysis., Omics: H3K4me1 ChIP-seq epigenome analysis., Omics: H3K36me3 ChIP-seq epigenome analysis., Omics: H3K27me3 ChIP-seq epigenome analysis., Omics: H3K27ac ChIP-seq epigenome analysis., Omics: CTCF ChIP-seq epigenome analysis., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: ENCODE project common cell types; tier 1., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misclassified. Originally thought to be a hepatocellular carcinoma cell line but shown to be from an hepatoblastoma (PubMed=19751877).., Group: Patented cell line.
|
PMID:233137
PMID:2439335
PMID:6248960
PMID:6288577
PMID:7972006
PMID:8050184
PMID:8224613
PMID:8384076
PMID:8389256
PMID:8835345
PMID:9178645
PMID:9359923
PMID:11050057
PMID:11416159
PMID:11981770
PMID:12029633
PMID:12068308
PMID:14980111
PMID:15767549
PMID:16181800
PMID:16935386
PMID:17254797
PMID:19215227
PMID:19751877
PMID:20069059
PMID:20215515
PMID:20228232
PMID:20937217
PMID:21269460
PMID:22278370
PMID:22460905
PMID:23325432
PMID:23505090
PMID:23887712
PMID:24116068
PMID:24618588
PMID:25485619
PMID:25574106
PMID:25877200
PMID:25960936
PMID:26160117
PMID:26589293
PMID:26825538
PMID:27027780
PMID:27329724
PMID:27470094
PMID:28196595
PMID:29610054
PMID:29660373
PMID:30629668
PMID:30864654
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
PMID:31395879
PMID:31561354
PMID:31978347
PMID:32471280
PMID:32899426
PMID:34320349
|
Cancer cell line
|
Male |
HEP-G2, Hep G2, HEP G2, HepG2, HEPG2 |
|
|
BTO:BTO_0000599,
CLO:CLO_0003704,
CLO:CLO_0003713,
CLO:CLO_0050856,
CLO:CLO_0050858,
EFO:EFO_0001187,
MCCL:MCC:0000222,
CLDB:cl1635,
CLDB:cl1636,
CLDB:cl1637,
CLDB:cl1638,
CLDB:cl1639,
CLDB:cl1641,
CLDB:cl1642,
CLDB:cl1643,
CLDB:cl1644,
CLDB:cl4910,
Abcam:ab257304,
Abcam:ab275467,
AddexBio:C0015002/46,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-6919,
ATCC:HB-8065,
BCRC:60025,
BCRJ:0103,
BioGRID_ORCS_Cell_line:809,
BioSample:SAMN01821557,
BioSample:SAMN01821681,
BioSample:SAMN03472183,
BioSample:SAMN10988201,
cancercelllines:CVCL_0027,
CCRID:1101HUM-PUMC000035,
CCRID:3101HUMSCSP510,
CCRID:3101HUMTCHu72,
CCRID:4201HUM-CCTCC00024,
CCRID:5301HUM-KCB05007YJ,
CCTCC:GDC0024,
Cell_Model_Passport:SIDM00904,
CGH-DB:9068-4,
ChEMBL-Cells:CHEMBL3307718,
ChEMBL-Targets:CHEMBL395,
CLS:300198,
Cosmic:690746,
Cosmic:724821,
Cosmic:852774,
Cosmic:869169,
Cosmic:869298,
Cosmic:871510,
Cosmic:873392,
Cosmic:873713,
Cosmic:928138,
Cosmic:932989,
Cosmic:934550,
Cosmic:945158,
Cosmic:948062,
Cosmic:979732,
Cosmic:999850,
Cosmic:1060080,
Cosmic:1187331,
Cosmic:1351511,
Cosmic:1499246,
Cosmic:1518227,
Cosmic:1628386,
Cosmic:2162525,
Cosmic:2301556,
Cosmic:2321029,
Cosmic:2560244,
Cosmic:2668285,
Cosmic:2674233,
Cosmic:2773180,
DepMap:ACH-000739,
DSMZ:ACC-180,
DSMZCellDive:ACC-180,
ECACC:85011430,
EGA:EGAS00001000610,
ENCODE:ENCBS002KIX,
ENCODE:ENCBS005KKO,
ENCODE:ENCBS005NKZ,
ENCODE:ENCBS006INV,
ENCODE:ENCBS009AVS,
ENCODE:ENCBS011BYX,
ENCODE:ENCBS011NDE,
ENCODE:ENCBS012DTZ,
ENCODE:ENCBS013LLU,
ENCODE:ENCBS015PAC,
ENCODE:ENCBS016WDR,
ENCODE:ENCBS017VYZ,
ENCODE:ENCBS018BAD,
ENCODE:ENCBS018WXY,
ENCODE:ENCBS019LAC,
ENCODE:ENCBS019QTJ,
ENCODE:ENCBS019XED,
ENCODE:ENCBS020YDI,
ENCODE:ENCBS021UTC,
ENCODE:ENCBS023JBH,
ENCODE:ENCBS024EHA,
ENCODE:ENCBS025AAW,
ENCODE:ENCBS030GWA,
ENCODE:ENCBS030ZIT,
ENCODE:ENCBS033QJG,
ENCODE:ENCBS034ENA,
ENCODE:ENCBS034PYO,
ENCODE:ENCBS035IIS,
ENCODE:ENCBS038OUO,
ENCODE:ENCBS038ZQB,
ENCODE:ENCBS039DPC,
ENCODE:ENCBS039XPI,
ENCODE:ENCBS040DES,
ENCODE:ENCBS040EJF,
ENCODE:ENCBS040QBA,
ENCODE:ENCBS041GAW,
ENCODE:ENCBS042JDA,
ENCODE:ENCBS044VWV,
ENCODE:ENCBS045GOD,
ENCODE:ENCBS045OVM,
ENCODE:ENCBS048XFP,
ENCODE:ENCBS049KBY,
ENCODE:ENCBS049QKG,
ENCODE:ENCBS049RJI,
ENCODE:ENCBS051IBT,
ENCODE:ENCBS053QGR,
ENCODE:ENCBS053TZY,
ENCODE:ENCBS055KDL,
ENCODE:ENCBS056VWP,
ENCODE:ENCBS060DQW,
ENCODE:ENCBS061GMD,
ENCODE:ENCBS061GZI,
ENCODE:ENCBS063CQL,
ENCODE:ENCBS063KED,
ENCODE:ENCBS065LQD,
ENCODE:ENCBS066SAB,
ENCODE:ENCBS066SXT,
ENCODE:ENCBS067QSF,
ENCODE:ENCBS068DNA,
ENCODE:ENCBS070YKP,
ENCODE:ENCBS072JEO,
ENCODE:ENCBS074GMS,
ENCODE:ENCBS074IZI,
ENCODE:ENCBS074PUV,
ENCODE:ENCBS074YUC,
ENCODE:ENCBS075HYT,
ENCODE:ENCBS076HTW,
ENCODE:ENCBS077CZP,
ENCODE:ENCBS077NMC,
ENCODE:ENCBS085GSG,
ENCODE:ENCBS085IZZ,
ENCODE:ENCBS086PXC,
ENCODE:ENCBS086XEN,
ENCODE:ENCBS087QWF,
ENCODE:ENCBS088KUZ,
ENCODE:ENCBS089VZP,
ENCODE:ENCBS091JMF,
ENCODE:ENCBS093QOO,
ENCODE:ENCBS096XGH,
ENCODE:ENCBS101LFX,
ENCODE:ENCBS101OYY,
ENCODE:ENCBS103LSZ,
ENCODE:ENCBS104QEK,
ENCODE:ENCBS106DQT,
ENCODE:ENCBS108PEU,
ENCODE:ENCBS109EEN,
ENCODE:ENCBS110FVC,
ENCODE:ENCBS111IHC,
ENCODE:ENCBS113GKP,
ENCODE:ENCBS114ENC,
ENCODE:ENCBS114MFP,
ENCODE:ENCBS116IFC,
ENCODE:ENCBS116LNU,
ENCODE:ENCBS117BTL,
ENCODE:ENCBS118LZR,
ENCODE:ENCBS120JBW,
ENCODE:ENCBS121IFK,
ENCODE:ENCBS121QNT,
ENCODE:ENCBS122WEH,
ENCODE:ENCBS127GXY,
ENCODE:ENCBS129BNW,
ENCODE:ENCBS130RRG,
ENCODE:ENCBS132XIH,
ENCODE:ENCBS133GYV,
ENCODE:ENCBS134OGP,
ENCODE:ENCBS135IEJ,
ENCODE:ENCBS135KID,
ENCODE:ENCBS136HQP,
ENCODE:ENCBS137REJ,
ENCODE:ENCBS138OWD,
ENCODE:ENCBS141IFN,
ENCODE:ENCBS142FZQ,
ENCODE:ENCBS143CPJ,
ENCODE:ENCBS143EIV,
ENCODE:ENCBS144MRF,
ENCODE:ENCBS145HYP,
ENCODE:ENCBS145YLE,
ENCODE:ENCBS147BEL,
ENCODE:ENCBS148AQX,
ENCODE:ENCBS148BFZ,
ENCODE:ENCBS149ZGY,
ENCODE:ENCBS150SBN,
ENCODE:ENCBS151OFF,
ENCODE:ENCBS152RQC,
ENCODE:ENCBS157CAN,
ENCODE:ENCBS157PJQ,
ENCODE:ENCBS158MMF,
ENCODE:ENCBS158NUW,
ENCODE:ENCBS164KGU,
ENCODE:ENCBS171TJQ,
ENCODE:ENCBS172NZN,
ENCODE:ENCBS173ACT,
ENCODE:ENCBS175ALJ,
ENCODE:ENCBS176LHZ,
ENCODE:ENCBS178ASF,
ENCODE:ENCBS180AZS,
ENCODE:ENCBS180QVY,
ENCODE:ENCBS180UZG,
ENCODE:ENCBS181KHF,
ENCODE:ENCBS183QJT,
ENCODE:ENCBS192GTP,
ENCODE:ENCBS194AMD,
ENCODE:ENCBS197XGU,
ENCODE:ENCBS199RMB,
ENCODE:ENCBS199ZPD,
ENCODE:ENCBS200OKV,
ENCODE:ENCBS201IDJ,
ENCODE:ENCBS202CLF,
ENCODE:ENCBS204FOO,
ENCODE:ENCBS204QRM,
ENCODE:ENCBS205JEO,
ENCODE:ENCBS207OWT,
ENCODE:ENCBS208CBB,
ENCODE:ENCBS210MLW,
ENCODE:ENCBS210TEK,
ENCODE:ENCBS213GIX,
ENCODE:ENCBS217MRJ,
ENCODE:ENCBS218GVF,
ENCODE:ENCBS218PEV,
ENCODE:ENCBS221OJT,
ENCODE:ENCBS222ZOM,
ENCODE:ENCBS224CAS,
ENCODE:ENCBS224IXA,
ENCODE:ENCBS224OGG,
ENCODE:ENCBS225ERF,
ENCODE:ENCBS226JWQ,
ENCODE:ENCBS228TBM,
ENCODE:ENCBS230TCM,
ENCODE:ENCBS231CTX,
ENCODE:ENCBS232MEB,
ENCODE:ENCBS233NIP,
ENCODE:ENCBS236NEP,
ENCODE:ENCBS237FEL,
ENCODE:ENCBS237TGJ,
ENCODE:ENCBS239AGG,
ENCODE:ENCBS242YTF,
ENCODE:ENCBS243GXZ,
ENCODE:ENCBS246HTK,
ENCODE:ENCBS248XEV,
ENCODE:ENCBS250DDC,
ENCODE:ENCBS250EAA,
ENCODE:ENCBS250QAH,
ENCODE:ENCBS252ZVH,
ENCODE:ENCBS253SJT,
ENCODE:ENCBS254GTY,
ENCODE:ENCBS254RNF,
ENCODE:ENCBS257TYR,
ENCODE:ENCBS257WFM,
ENCODE:ENCBS258IBQ,
ENCODE:ENCBS260QIN,
ENCODE:ENCBS260UFW,
ENCODE:ENCBS261BDP,
ENCODE:ENCBS263MSZ,
ENCODE:ENCBS266IRW,
ENCODE:ENCBS267AEP,
ENCODE:ENCBS269MQH,
ENCODE:ENCBS269MQV,
ENCODE:ENCBS269TMY,
ENCODE:ENCBS269UBV,
ENCODE:ENCBS270KOG,
ENCODE:ENCBS271FCJ,
ENCODE:ENCBS271WON,
ENCODE:ENCBS272IWF,
ENCODE:ENCBS273MKT,
ENCODE:ENCBS275NVW,
ENCODE:ENCBS280KDG,
ENCODE:ENCBS281JZX,
ENCODE:ENCBS282XVK,
ENCODE:ENCBS285EHM,
ENCODE:ENCBS287NGC,
ENCODE:ENCBS287RQP,
ENCODE:ENCBS289AAB,
ENCODE:ENCBS289IAE,
ENCODE:ENCBS292XKE,
ENCODE:ENCBS294TYB,
ENCODE:ENCBS295BTT,
ENCODE:ENCBS295NFS,
ENCODE:ENCBS296ABO,
ENCODE:ENCBS296SQC,
ENCODE:ENCBS296VMM,
ENCODE:ENCBS297BHJ,
ENCODE:ENCBS299YGH,
ENCODE:ENCBS300GHC,
ENCODE:ENCBS300YFU,
ENCODE:ENCBS301IGN,
ENCODE:ENCBS301LDQ,
ENCODE:ENCBS303VDB,
ENCODE:ENCBS306CIA,
ENCODE:ENCBS307OQZ,
ENCODE:ENCBS308ZPA,
ENCODE:ENCBS309MNT,
ENCODE:ENCBS310TGK,
ENCODE:ENCBS311FWL,
ENCODE:ENCBS313GMZ,
ENCODE:ENCBS313IHS,
ENCODE:ENCBS314VPT,
ENCODE:ENCBS315MGA,
ENCODE:ENCBS315PDD,
ENCODE:ENCBS319FAN,
ENCODE:ENCBS321SWI,
ENCODE:ENCBS322SEN,
ENCODE:ENCBS333JNJ,
ENCODE:ENCBS334CNK,
ENCODE:ENCBS335TOC,
ENCODE:ENCBS336RRO,
ENCODE:ENCBS337HXQ,
ENCODE:ENCBS337WJM,
ENCODE:ENCBS337WWP,
ENCODE:ENCBS338VUB,
ENCODE:ENCBS339GWD,
ENCODE:ENCBS339SIT,
ENCODE:ENCBS341ITG,
ENCODE:ENCBS342VWN,
ENCODE:ENCBS344JWL,
ENCODE:ENCBS344VFK,
ENCODE:ENCBS346DEZ,
ENCODE:ENCBS346EFV,
ENCODE:ENCBS349HZS,
ENCODE:ENCBS351JCJ,
ENCODE:ENCBS352ZNU,
ENCODE:ENCBS354HQF,
ENCODE:ENCBS354PIF,
ENCODE:ENCBS354ZLY,
ENCODE:ENCBS356MOV,
ENCODE:ENCBS357UNN,
ENCODE:ENCBS358XLG,
ENCODE:ENCBS362ASG,
ENCODE:ENCBS363GXU,
ENCODE:ENCBS366VYI,
ENCODE:ENCBS367TIL,
ENCODE:ENCBS374CKM,
ENCODE:ENCBS375JNA,
ENCODE:ENCBS380ZOW,
ENCODE:ENCBS381BBR,
ENCODE:ENCBS385LUB,
ENCODE:ENCBS399FDJ,
ENCODE:ENCBS399GAF,
ENCODE:ENCBS399MFO,
ENCODE:ENCBS400CWC,
ENCODE:ENCBS401LBP,
ENCODE:ENCBS402BUA,
ENCODE:ENCBS402VZL,
ENCODE:ENCBS403UGF,
ENCODE:ENCBS404EOZ,
ENCODE:ENCBS405FLI,
ENCODE:ENCBS405JBR,
ENCODE:ENCBS408JNN,
ENCODE:ENCBS408PDS,
ENCODE:ENCBS409PKR,
ENCODE:ENCBS409RQS,
ENCODE:ENCBS413HHW,
ENCODE:ENCBS415VLW,
ENCODE:ENCBS416UEF,
ENCODE:ENCBS416YET,
ENCODE:ENCBS421OZB,
ENCODE:ENCBS422FYC,
ENCODE:ENCBS423OQV,
ENCODE:ENCBS423ZZH,
ENCODE:ENCBS425BJH,
ENCODE:ENCBS425CUD,
ENCODE:ENCBS429YJD,
ENCODE:ENCBS430PSA,
ENCODE:ENCBS431NPJ,
ENCODE:ENCBS433CTJ,
ENCODE:ENCBS433TIQ,
ENCODE:ENCBS433UJJ,
ENCODE:ENCBS435MPV,
ENCODE:ENCBS435NIB,
ENCODE:ENCBS435NSE,
ENCODE:ENCBS437FDB,
ENCODE:ENCBS437UIO,
ENCODE:ENCBS440GZN,
ENCODE:ENCBS440MJL,
ENCODE:ENCBS441XTP,
ENCODE:ENCBS443JPP,
ENCODE:ENCBS444MVG,
ENCODE:ENCBS444QIJ,
ENCODE:ENCBS446KHP,
ENCODE:ENCBS447JNO,
ENCODE:ENCBS449AIA,
ENCODE:ENCBS449LCQ,
ENCODE:ENCBS453TYZ,
ENCODE:ENCBS455OVD,
ENCODE:ENCBS456NEZ,
ENCODE:ENCBS458WEZ,
ENCODE:ENCBS463HNE,
ENCODE:ENCBS464VEI,
ENCODE:ENCBS465DEI,
ENCODE:ENCBS466PDL,
ENCODE:ENCBS466ZIX,
ENCODE:ENCBS467HWM,
ENCODE:ENCBS467XVF,
ENCODE:ENCBS470TSC,
ENCODE:ENCBS470XDJ,
ENCODE:ENCBS471DUZ,
ENCODE:ENCBS471EIZ,
ENCODE:ENCBS472BZM,
ENCODE:ENCBS474AND,
ENCODE:ENCBS475AHQ,
ENCODE:ENCBS476TPW,
ENCODE:ENCBS479IBT,
ENCODE:ENCBS479RLA,
ENCODE:ENCBS481IVE,
ENCODE:ENCBS483WGW,
ENCODE:ENCBS484TBT,
ENCODE:ENCBS485OKN,
ENCODE:ENCBS486CUL,
ENCODE:ENCBS486YWI,
ENCODE:ENCBS487KTY,
ENCODE:ENCBS487SZV,
ENCODE:ENCBS488HLS,
ENCODE:ENCBS488UTE,
ENCODE:ENCBS489ZQI,
ENCODE:ENCBS491TZK,
ENCODE:ENCBS492SDY,
ENCODE:ENCBS495SHD,
ENCODE:ENCBS497AGN,
ENCODE:ENCBS501AJE,
ENCODE:ENCBS501FGJ,
ENCODE:ENCBS502APU,
ENCODE:ENCBS502FPQ,
ENCODE:ENCBS503ZYE,
ENCODE:ENCBS504IUW,
ENCODE:ENCBS504VHS,
ENCODE:ENCBS505LMC,
ENCODE:ENCBS506FKT,
ENCODE:ENCBS508YFO,
ENCODE:ENCBS510FFO,
ENCODE:ENCBS511ZQV,
ENCODE:ENCBS515IJA,
ENCODE:ENCBS515KFV,
ENCODE:ENCBS516TKV,
ENCODE:ENCBS520MGH,
ENCODE:ENCBS522AAA,
ENCODE:ENCBS523AAA,
ENCODE:ENCBS524YUI,
ENCODE:ENCBS525TLA,
ENCODE:ENCBS530ENF,
ENCODE:ENCBS530LIV,
ENCODE:ENCBS530VUT,
ENCODE:ENCBS531RMF,
ENCODE:ENCBS533IVT,
ENCODE:ENCBS537ADD,
ENCODE:ENCBS540JSU,
ENCODE:ENCBS540MOP,
ENCODE:ENCBS541YFT,
ENCODE:ENCBS542DRS,
ENCODE:ENCBS542YDW,
ENCODE:ENCBS544ETZ,
ENCODE:ENCBS544WQP,
ENCODE:ENCBS546FZO,
ENCODE:ENCBS547FPL,
ENCODE:ENCBS547JWV,
ENCODE:ENCBS548DDM,
ENCODE:ENCBS548DJV,
ENCODE:ENCBS550FNB,
ENCODE:ENCBS550RQC,
ENCODE:ENCBS551CUU,
ENCODE:ENCBS551DVZ,
ENCODE:ENCBS551QFT,
ENCODE:ENCBS553PEJ,
ENCODE:ENCBS554TEZ,
ENCODE:ENCBS555BYF,
ENCODE:ENCBS555IZN,
ENCODE:ENCBS556YSM,
ENCODE:ENCBS557NDG,
ENCODE:ENCBS560TQP,
ENCODE:ENCBS561LQQ,
ENCODE:ENCBS562WFV,
ENCODE:ENCBS571XTM,
ENCODE:ENCBS573EMA,
ENCODE:ENCBS573OLZ,
ENCODE:ENCBS574ZRE,
ENCODE:ENCBS575HTN,
ENCODE:ENCBS575NGC,
ENCODE:ENCBS576NFP,
ENCODE:ENCBS577XCP,
ENCODE:ENCBS579HCA,
ENCODE:ENCBS581BGT,
ENCODE:ENCBS581REI,
ENCODE:ENCBS582KNJ,
ENCODE:ENCBS582REX,
ENCODE:ENCBS590WTW,
ENCODE:ENCBS591PPP,
ENCODE:ENCBS595FPT,
ENCODE:ENCBS598VSF,
ENCODE:ENCBS599QJL,
ENCODE:ENCBS600ITX,
ENCODE:ENCBS604BAZ,
ENCODE:ENCBS607IVB,
ENCODE:ENCBS608AFV,
ENCODE:ENCBS608OON,
ENCODE:ENCBS610IGG,
ENCODE:ENCBS610UML,
ENCODE:ENCBS611LWG,
ENCODE:ENCBS611PFD,
ENCODE:ENCBS611WLI,
ENCODE:ENCBS612GBT,
ENCODE:ENCBS614CMA,
ENCODE:ENCBS619EOB,
ENCODE:ENCBS619OWS,
ENCODE:ENCBS621TAB,
ENCODE:ENCBS623BZF,
ENCODE:ENCBS623OHX,
ENCODE:ENCBS623YQT,
ENCODE:ENCBS624DUS,
ENCODE:ENCBS624MLL,
ENCODE:ENCBS626BOT,
ENCODE:ENCBS628IQK,
ENCODE:ENCBS628MMK,
ENCODE:ENCBS628ONB,
ENCODE:ENCBS632SNG,
ENCODE:ENCBS634THO,
ENCODE:ENCBS635NSH,
ENCODE:ENCBS636ANV,
ENCODE:ENCBS637UJM,
ENCODE:ENCBS638AAA,
ENCODE:ENCBS638ASL,
ENCODE:ENCBS638MWB,
ENCODE:ENCBS641AVI,
ENCODE:ENCBS644PWW,
ENCODE:ENCBS644SVK,
ENCODE:ENCBS645YGY,
ENCODE:ENCBS646RDV,
ENCODE:ENCBS648DPW,
ENCODE:ENCBS650CRD,
ENCODE:ENCBS650SLE,
ENCODE:ENCBS654ERN,
ENCODE:ENCBS656AXT,
ENCODE:ENCBS662HXP,
ENCODE:ENCBS662TZZ,
ENCODE:ENCBS664KGZ,
ENCODE:ENCBS664MRR,
ENCODE:ENCBS665IBY,
ENCODE:ENCBS665LZL,
ENCODE:ENCBS667BFL,
ENCODE:ENCBS667GKM,
ENCODE:ENCBS668RFG,
ENCODE:ENCBS669DWT,
ENCODE:ENCBS670FFG,
ENCODE:ENCBS671AAA,
ENCODE:ENCBS671WOF,
ENCODE:ENCBS672AAA,
ENCODE:ENCBS672UJA,
ENCODE:ENCBS673AAA,
ENCODE:ENCBS673ABW,
ENCODE:ENCBS674AAA,
ENCODE:ENCBS675AAA,
ENCODE:ENCBS676AAA,
ENCODE:ENCBS680YLF,
ENCODE:ENCBS684ULB,
ENCODE:ENCBS686ZOG,
ENCODE:ENCBS689DEE,
ENCODE:ENCBS690KCY,
ENCODE:ENCBS692AEI,
ENCODE:ENCBS692BSS,
ENCODE:ENCBS692HLB,
ENCODE:ENCBS694IAG,
ENCODE:ENCBS696KRJ,
ENCODE:ENCBS696RMN,
ENCODE:ENCBS697FZF,
ENCODE:ENCBS697NJJ,
ENCODE:ENCBS699OCX,
ENCODE:ENCBS702HBU,
ENCODE:ENCBS702PRB,
ENCODE:ENCBS704AVG,
ENCODE:ENCBS704TEF,
ENCODE:ENCBS704YEM,
ENCODE:ENCBS705HMQ,
ENCODE:ENCBS705NHL,
ENCODE:ENCBS706BWK,
ENCODE:ENCBS712AAA,
ENCODE:ENCBS713BFI,
ENCODE:ENCBS713IGS,
ENCODE:ENCBS714CLI,
ENCODE:ENCBS715MWV,
ENCODE:ENCBS715WYI,
ENCODE:ENCBS716VBH,
ENCODE:ENCBS716YFX,
ENCODE:ENCBS717MSF,
ENCODE:ENCBS717QJM,
ENCODE:ENCBS718VVA,
ENCODE:ENCBS719JYV,
ENCODE:ENCBS719OUD,
ENCODE:ENCBS720SBS,
ENCODE:ENCBS721RXI,
ENCODE:ENCBS722LIJ,
ENCODE:ENCBS722TNF,
ENCODE:ENCBS727GLB,
ENCODE:ENCBS727VRH,
ENCODE:ENCBS729TZG,
ENCODE:ENCBS730DQI,
ENCODE:ENCBS731WFK,
ENCODE:ENCBS732KTS,
ENCODE:ENCBS732PJR,
ENCODE:ENCBS734JXY,
ENCODE:ENCBS734KAG,
ENCODE:ENCBS738ADY,
ENCODE:ENCBS739HLB,
ENCODE:ENCBS739PTC,
ENCODE:ENCBS740FAU,
ENCODE:ENCBS740NNE,
ENCODE:ENCBS740QWK,
ENCODE:ENCBS741AAA,
ENCODE:ENCBS741RGH,
ENCODE:ENCBS741YEQ,
ENCODE:ENCBS742AAA,
ENCODE:ENCBS742SWZ,
ENCODE:ENCBS743AAA,
ENCODE:ENCBS743JKX,
ENCODE:ENCBS743RUU,
ENCODE:ENCBS743ZMW,
ENCODE:ENCBS744AAA,
ENCODE:ENCBS745AAA,
ENCODE:ENCBS745AQT,
ENCODE:ENCBS745UGC,
ENCODE:ENCBS746AAA,
ENCODE:ENCBS747KOI,
ENCODE:ENCBS747MTP,
ENCODE:ENCBS748YQE,
ENCODE:ENCBS749JUQ,
ENCODE:ENCBS751GYX,
ENCODE:ENCBS751KWS,
ENCODE:ENCBS753KCK,
ENCODE:ENCBS754KRB,
ENCODE:ENCBS755JGR,
ENCODE:ENCBS755NZH,
ENCODE:ENCBS756FJO,
ENCODE:ENCBS757QFO,
ENCODE:ENCBS760ISV,
ENCODE:ENCBS762HAX,
ENCODE:ENCBS763BBP,
ENCODE:ENCBS765FVI,
ENCODE:ENCBS767KUR,
ENCODE:ENCBS767MPH,
ENCODE:ENCBS767YCA,
ENCODE:ENCBS768GCL,
ENCODE:ENCBS768ZGL,
ENCODE:ENCBS771QGO,
ENCODE:ENCBS773AAA,
ENCODE:ENCBS773GMP,
ENCODE:ENCBS774QLP,
ENCODE:ENCBS775MDU,
ENCODE:ENCBS775NGD,
ENCODE:ENCBS775RGP,
ENCODE:ENCBS777STD,
ENCODE:ENCBS777UEV,
ENCODE:ENCBS777VZC,
ENCODE:ENCBS778JAH,
ENCODE:ENCBS778LCM,
ENCODE:ENCBS779XEH,
ENCODE:ENCBS780BKX,
ENCODE:ENCBS780HTG,
ENCODE:ENCBS781AWJ,
ENCODE:ENCBS781BOJ,
ENCODE:ENCBS781RAA,
ENCODE:ENCBS782BXQ,
ENCODE:ENCBS783AYY,
ENCODE:ENCBS783PVI,
ENCODE:ENCBS783YSP,
ENCODE:ENCBS786WUO,
ENCODE:ENCBS787BXG,
ENCODE:ENCBS787RAZ,
ENCODE:ENCBS789ZNN,
ENCODE:ENCBS791ETZ,
ENCODE:ENCBS791FZV,
ENCODE:ENCBS793GXQ,
ENCODE:ENCBS798HNT,
ENCODE:ENCBS798MOH,
ENCODE:ENCBS798PZJ,
ENCODE:ENCBS799LNH,
ENCODE:ENCBS799SQC,
ENCODE:ENCBS800QIW,
ENCODE:ENCBS803IPJ,
ENCODE:ENCBS803ZJJ,
ENCODE:ENCBS805PXD,
ENCODE:ENCBS805UZF,
ENCODE:ENCBS806AAA,
ENCODE:ENCBS807AAA,
ENCODE:ENCBS808XDL,
ENCODE:ENCBS809KDQ,
ENCODE:ENCBS810BDN,
ENCODE:ENCBS810JOY,
ENCODE:ENCBS811GQK,
ENCODE:ENCBS811PND,
ENCODE:ENCBS813FSC,
ENCODE:ENCBS814VTY,
ENCODE:ENCBS815MFP,
ENCODE:ENCBS816PYX,
ENCODE:ENCBS817DXX,
ENCODE:ENCBS817KQF,
ENCODE:ENCBS817NZJ,
ENCODE:ENCBS818CDN,
ENCODE:ENCBS821ETN,
ENCODE:ENCBS821PLV,
ENCODE:ENCBS824AAA,
ENCODE:ENCBS824QCP,
ENCODE:ENCBS825AAA,
ENCODE:ENCBS826AAA,
ENCODE:ENCBS827QKB,
ENCODE:ENCBS832ULV,
ENCODE:ENCBS835AAA,
ENCODE:ENCBS835EOX,
ENCODE:ENCBS835UPQ,
ENCODE:ENCBS836AAA,
ENCODE:ENCBS836LJE,
ENCODE:ENCBS837AAA,
ENCODE:ENCBS837YEZ,
ENCODE:ENCBS838SRU,
ENCODE:ENCBS839SGI,
ENCODE:ENCBS840QTY,
ENCODE:ENCBS842MLZ,
ENCODE:ENCBS844EBE,
ENCODE:ENCBS845QPP,
ENCODE:ENCBS847PBZ,
ENCODE:ENCBS848AAA,
ENCODE:ENCBS849AAA,
ENCODE:ENCBS849LND,
ENCODE:ENCBS850PLY,
ENCODE:ENCBS851ZNE,
ENCODE:ENCBS853NQW,
ENCODE:ENCBS854HTL,
ENCODE:ENCBS856GWK,
ENCODE:ENCBS856PWK,
ENCODE:ENCBS857THE,
ENCODE:ENCBS858AAA,
ENCODE:ENCBS859AAA,
ENCODE:ENCBS859FFE,
ENCODE:ENCBS859RAZ,
ENCODE:ENCBS860AAA,
ENCODE:ENCBS861HMN,
ENCODE:ENCBS862LXP,
ENCODE:ENCBS863WKZ,
ENCODE:ENCBS864WAF,
ENCODE:ENCBS864XFG,
ENCODE:ENCBS865ZOH,
ENCODE:ENCBS866LUZ,
ENCODE:ENCBS868JIC,
ENCODE:ENCBS869GQP,
ENCODE:ENCBS869WAH,
ENCODE:ENCBS870TBE,
ENCODE:ENCBS872AMP,
ENCODE:ENCBS872GDG,
ENCODE:ENCBS873PJJ,
ENCODE:ENCBS875LKB,
ENCODE:ENCBS877GRH,
ENCODE:ENCBS877WFF,
ENCODE:ENCBS879GXJ,
ENCODE:ENCBS879MRD,
ENCODE:ENCBS881CIF,
ENCODE:ENCBS882YXM,
ENCODE:ENCBS883DWI,
ENCODE:ENCBS885FSX,
ENCODE:ENCBS885JQS,
ENCODE:ENCBS885ORM,
ENCODE:ENCBS887RIJ,
ENCODE:ENCBS889CYZ,
ENCODE:ENCBS890WPB,
ENCODE:ENCBS892VZB,
ENCODE:ENCBS895EOS,
ENCODE:ENCBS895HRB,
ENCODE:ENCBS896YYX,
ENCODE:ENCBS897BFW,
ENCODE:ENCBS897HQV,
ENCODE:ENCBS899ZNE,
ENCODE:ENCBS900XSC,
ENCODE:ENCBS901YOY,
ENCODE:ENCBS902IAH,
ENCODE:ENCBS904EKE,
ENCODE:ENCBS905ULQ,
ENCODE:ENCBS907KSW,
ENCODE:ENCBS909PJP,
ENCODE:ENCBS910PZQ,
ENCODE:ENCBS910ZFQ,
ENCODE:ENCBS912TCF,
ENCODE:ENCBS913KLP,
ENCODE:ENCBS914FGT,
ENCODE:ENCBS918RGX,
ENCODE:ENCBS923MFQ,
ENCODE:ENCBS924KDO,
ENCODE:ENCBS924WYL,
ENCODE:ENCBS926EJR,
ENCODE:ENCBS927AKA,
ENCODE:ENCBS928CHW,
ENCODE:ENCBS930FIG,
ENCODE:ENCBS931EXY,
ENCODE:ENCBS931SHZ,
ENCODE:ENCBS935XAF,
ENCODE:ENCBS937BJO,
ENCODE:ENCBS937LVM,
ENCODE:ENCBS939AYV,
ENCODE:ENCBS943ASZ,
ENCODE:ENCBS945FES,
ENCODE:ENCBS948WDK,
ENCODE:ENCBS949DPY,
ENCODE:ENCBS949YDI,
ENCODE:ENCBS950MSQ,
ENCODE:ENCBS950TLN,
ENCODE:ENCBS955ZHF,
ENCODE:ENCBS956FFN,
ENCODE:ENCBS957WYL,
ENCODE:ENCBS959DVN,
ENCODE:ENCBS961ZJH,
ENCODE:ENCBS962POD,
ENCODE:ENCBS966ODK,
ENCODE:ENCBS967NRV,
ENCODE:ENCBS967UNG,
ENCODE:ENCBS967WNR,
ENCODE:ENCBS970EPG,
ENCODE:ENCBS974ELC,
ENCODE:ENCBS976OQX,
ENCODE:ENCBS976TOE,
ENCODE:ENCBS976ZOG,
ENCODE:ENCBS978CGB,
ENCODE:ENCBS982JDZ,
ENCODE:ENCBS983ECZ,
ENCODE:ENCBS983UEI,
ENCODE:ENCBS983YXQ,
ENCODE:ENCBS984EPA,
ENCODE:ENCBS985FRY,
ENCODE:ENCBS985WFY,
ENCODE:ENCBS985WNX,
ENCODE:ENCBS987BVJ,
ENCODE:ENCBS987KVB,
ENCODE:ENCBS989AFC,
ENCODE:ENCBS990SBY,
ENCODE:ENCBS991MPK,
ENCODE:ENCBS992ZRR,
ENCODE:ENCBS994RVB,
ENCODE:ENCBS994TMS,
ENCODE:ENCBS994VIY,
ENCODE:ENCBS995NXW,
ENCODE:ENCBS995WFW,
ENCODE:ENCBS998QYV,
GEO:GSM207049,
GEO:GSM472906,
GEO:GSM472907,
GEO:GSM481450,
GEO:GSM501780,
GEO:GSM565883,
GEO:GSM733638,
GEO:GSM733641,
GEO:GSM733645,
GEO:GSM733685,
GEO:GSM733693,
GEO:GSM733694,
GEO:GSM733737,
GEO:GSM733743,
GEO:GSM733754,
GEO:GSM733774,
GEO:GSM736637,
GEO:GSM736639,
GEO:GSM749683,
GEO:GSM749715,
GEO:GSM749756,
GEO:GSM782122,
GEO:GSM798321,
GEO:GSM803336,
GEO:GSM803343,
GEO:GSM803344,
GEO:GSM803367,
GEO:GSM803368,
GEO:GSM803381,
GEO:GSM803403,
GEO:GSM803404,
GEO:GSM803415,
GEO:GSM803418,
GEO:GSM803432,
GEO:GSM803449,
GEO:GSM803451,
GEO:GSM803452,
GEO:GSM803460,
GEO:GSM803461,
GEO:GSM803483,
GEO:GSM803486,
GEO:GSM803493,
GEO:GSM803499,
GEO:GSM803500,
GEO:GSM803502,
GEO:GSM803503,
GEO:GSM803507,
GEO:GSM803517,
GEO:GSM803527,
GEO:GSM803530,
GEO:GSM816662,
GEO:GSM822284,
GEO:GSM822287,
GEO:GSM822291,
GEO:GSM887079,
GEO:GSM888149,
GEO:GSM923446,
GEO:GSM935274,
GEO:GSM935275,
GEO:GSM935280,
GEO:GSM935304,
GEO:GSM935305,
GEO:GSM935306,
GEO:GSM935307,
GEO:GSM935335,
GEO:GSM935350,
GEO:GSM935364,
GEO:GSM935406,
GEO:GSM935437,
GEO:GSM935493,
GEO:GSM935542,
GEO:GSM935543,
GEO:GSM935545,
GEO:GSM935566,
GEO:GSM935579,
GEO:GSM935596,
GEO:GSM935603,
GEO:GSM935609,
GEO:GSM935610,
GEO:GSM935646,
GEO:GSM935647,
GEO:GSM935648,
GEO:GSM935649,
GEO:GSM935650,
GEO:GSM936760,
GEO:GSM945182,
GEO:GSM945211,
GEO:GSM945231,
GEO:GSM945291,
GEO:GSM1003487,
GEO:GSM1003519,
GEO:GSM1010740,
GEO:GSM1010741,
GEO:GSM1010777,
GEO:GSM1010778,
GEO:GSM1010784,
GEO:GSM1010787,
GEO:GSM1010808,
GEO:GSM1010809,
GEO:GSM1010810,
GEO:GSM1010821,
GEO:GSM1010831,
GEO:GSM1010865,
GEO:GSM1010875,
GEO:GSM1010876,
GEO:GSM1040305,
GEO:GSM1040375,
GEO:GSM1374138,
GEO:GSM1374139,
GEO:GSM1374140,
GEO:GSM1374141,
GEO:GSM1374142,
GEO:GSM1374143,
GEO:GSM1374144,
GEO:GSM1374145,
GEO:GSM1374146,
GEO:GSM1374147,
GEO:GSM1374148,
GEO:GSM1374532,
GEO:GSM1669878,
GEO:GSM2423739,
GEO:GSM2423740,
GEO:GSM2551565,
IARC_TP53:30037,
IBRC:C10096,
ICLC:HTL95005,
IGRhCellID:HepG2,
IZSLER:BS TCL 79,
JCRB:JCRB1054,
JCRB:NIHS0326,
KCB:KCB 200507YJ,
KCLB:88065,
LiGeA:CCLE_410,
LIMORE:HepG2,
LINCS_LDP:LCL-1925,
Lonza:62,
MetaboLights:MTBLS127,
MetaboLights:MTBLS419,
MetaboLights:MTBLS582,
MetaboLights:MTBLS1358,
NCBI_Iran:C158,
PharmacoDB:HepG2_539_2019,
PRIDE:PXD000661,
PRIDE:PXD001874,
PRIDE:PXD002395,
PRIDE:PXD003370,
PRIDE:PXD004252,
PRIDE:PXD005955,
PRIDE:PXD008190,
PRIDE:PXD008613,
PRIDE:PXD010142,
PRIDE:PXD018373,
PRIDE:PXD018450,
PRIDE:PXD024206,
Progenetix:CVCL_0027,
PubChem_Cell_line:CVCL_0027,
RCB:RCB0459,
RCB:RCB1648,
RCB:RCB1886,
TKG:TKG 0205,
TOKU-E:1440,
Ubigene:YC-C001,
Wikidata:Q5731621 |
|
|
CVCL_0027 |
2025-01-31 12:16:26 |
22210 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(RCB Cat# RCB1889, RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
RCB |
RCB1889 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
HEp-2
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
(CLS Cat# 300397, RRID:CVCL_1906)
|
|
|
Omics: Ubiquitination analysis by proteomics., Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Genome sequenced (low read coverage)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma..
|
PMID:566722
PMID:1246601
PMID:3180844
PMID:4203458
PMID:4864103
PMID:5641128
PMID:5668122
PMID:6988327
PMID:8397027
PMID:11416159
PMID:13209540
PMID:13261081
PMID:14185313
PMID:17254797
PMID:19450234
PMID:19941903
PMID:20143388
PMID:23925245
PMID:25485619
PMID:26589293
PMID:29483928
PMID:29967540
PMID:31105993
PMID:33389257
PMID:34024160
PMID:34697958
|
Cancer cell line
|
Female |
Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 |
CLS |
300397 |
BTO:BTO_0000976,
CLO:CLO_0003706,
CLO:CLO_0003707,
CLO:CLO_0050927,
EFO:EFO_0006438,
CLDB:cl1646,
CLDB:cl1647,
CLDB:cl1649,
CLDB:cl1650,
CLDB:cl1653,
CLDB:cl1654,
CLDB:cl1655,
AddexBio:C0050001/4983,
ArrayExpress:E-MTAB-2706,
ATCC:CCL-23,
BCRC:60042,
BCRJ:0101,
BioSample:SAMN03151706,
CCLV:CCLV-RIE 0141,
CCRID:1101HUM-PUMC000068,
CCRID:4201PAT-CCTCC00214,
CCTCC:GDC0004,
Cell_Model_Passport:SIDM01208,
ChEMBL-Cells:CHEMBL3307694,
ChEMBL-Targets:CHEMBL614735,
CLS:300397,
Cosmic:1339928,
Cosmic:1530739,
Cosmic:1969495,
Cosmic:2301559,
ECACC:86030501,
EGA:EGAS00001000610,
GEO:GSM1374529,
GEO:GSM1374530,
IZSLER:BS TCL 23,
KCLB:10023,
NCBI_Iran:C144,
PharmacoDB:HEp2_540_2019,
PRIDE:PXD006201,
PRIDE:PXD013072,
PRIDE:PXD014913,
PRIDE:PXD031726,
PubChem_Cell_line:CVCL_1906,
RCB:RCB1889,
TKG:TKG 0403,
TOKU-E:1442,
Wikidata:Q16554737 |
|
|
CVCL_1906 |
2025-01-31 12:16:25 |
2879 |
HMC-1-8
Resource Report
Resource Website
Discontinued
|
(RRID:CVCL_2949)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Deep exome analysis., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3488124
PMID:26589293
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
HMC18 |
|
|
CLO:CLO_0037257,
EFO:EFO_0022456,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:656,
BioSample:SAMN03470817,
BioSample:SAMN10987868,
cancercelllines:CVCL_2949,
Cell_Model_Passport:SIDM01622,
DepMap:ACH-000721,
IARC_TP53:28374,
JCRB:JCRB0166,
JCRB:FDSC0048,
LiGeA:CCLE_562,
PharmacoDB:HMC18_552_2019,
Progenetix:CVCL_2949,
SLKBase:3552,
Wikidata:Q54889908 |
|
|
CVCL_2949 |
2025-01-31 12:19:08 |
0 |
HNT-34
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_2071)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Deep exome analysis., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9266939
PMID:10071072
PMID:10576511
PMID:10637496
PMID:10739008
PMID:11226526
PMID:16408098
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
HNT34 |
|
|
CLO:CLO_0050982,
EFO:EFO_0006583,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN01821631,
BioSample:SAMN03472915,
BioSample:SAMN10989583,
cancercelllines:CVCL_2071,
Cell_Model_Passport:SIDM01621,
Cosmic:787435,
Cosmic:975253,
Cosmic:1012069,
Cosmic:1281316,
Cosmic:2306209,
Cosmic:2378086,
DepMap:ACH-000299,
DSMZ:ACC-600,
DSMZCellDive:ACC-600,
EGA:EGAS00001000610,
EGA:EGAS00001002554,
GEO:GSM1446757,
PharmacoDB:HNT34_558_2019,
RCB:RCB1296,
Wikidata:Q54890075 |
|
|
CVCL_2071 |
2025-01-31 12:19:14 |
2 |
HN
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1283)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: DNA methylation analysis., Omics: Deep exome analysis., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8985100
PMID:17390010
PMID:17719389
PMID:18423281
PMID:20164919
PMID:20215515
PMID:22460905
PMID:26589293
PMID:25485619
PMID:25877200
PMID:27397505
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0004589,
CLO:CLO_0003788,
CLDB:cl1701,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473149,
cancercelllines:CVCL_1283,
Cell_Model_Passport:SIDM01061,
ChEMBL-Cells:CHEMBL3308742,
ChEMBL-Targets:CHEMBL1075465,
Cosmic:907059,
Cosmic-CLP:907059,
DepMap:ACH-001090,
DSMZ:ACC-417,
DSMZCellDive:ACC-417,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907059,
GEO:GSM888158,
GEO:GSM1669887,
IARC_TP53:21376,
IARC_TP53:25037,
LINCS_LDP:LCL-1209,
PharmacoDB:HN_557_2019,
Progenetix:CVCL_1283,
PubChem_Cell_line:CVCL_1283,
Wikidata:Q54889984 |
|
|
CVCL_1283 |
2025-01-31 12:19:11 |
3 |
HMY-1
Resource Report
Resource Website
Discontinued
|
(RRID:CVCL_2950)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: SNP array analysis., Omics: Deep exome analysis., Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:6239887
PMID:25485619
PMID:25877200
PMID:26589293
|
Cancer cell line
|
Male |
HMY1 |
|
|
cancercelllines:CVCL_2950,
Cell_Model_Passport:SIDM01623,
DepMap:ACH-001522,
EFO:EFO_0006582,
ArrayExpress:E-MTAB-2706,
BioSample:SAMN03472869,
CLS:305145,
EGA:EGAS00001000610,
JCRB:JCRB1018,
JCRB:NIHS0252,
PharmacoDB:HMY1_556_2019,
Wikidata:Q54889978 |
|
|
CVCL_2950 |
2025-01-31 12:19:11 |
0 |
HPAC
Resource Report
Resource Website
10+ mentions
|
(RRID:CVCL_3517)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: shRNA library screening., Omics: Proteome analysis by 2D-DE/MS., Omics: Metabolome analysis., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Characteristics: Established from a nude mouse xenograft (ATCC=CRL-2119)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15367885
PMID:20215515
PMID:20418756
PMID:22460905
PMID:22585861
PMID:25167228
PMID:25485619
PMID:25877200
PMID:25939163
PMID:25984343
PMID:26216984
PMID:26589293
PMID:27259358
PMID:27397505
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
Hpac |
|
|
BTO:BTO_0004121,
CLO:CLO_0003814,
EFO:EFO_0002197,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2119,
BCRC:60495,
BioSample:SAMN03472247,
BioSample:SAMN10987698,
cancercelllines:CVCL_3517,
CCRID:1101HUM-PUMC000189,
Cell_Model_Passport:SIDM00670,
ChEMBL-Cells:CHEMBL3308388,
ChEMBL-Targets:CHEMBL612595,
Cosmic:913306,
Cosmic:1571784,
Cosmic:1995444,
Cosmic:2434094,
Cosmic-CLP:1298136,
DepMap:ACH-000270,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1298136,
GEO:GSM621897,
GEO:GSM206509,
GEO:GSM784701,
GEO:GSM887089,
GEO:GSM888160,
GEO:GSM1024401,
GEO:GSM1374545,
GEO:GSM1669892,
IARC_TP53:21070,
IGRhCellID:HPAC,
LiGeA:CCLE_795,
LINCS_LDP:LCL-1735,
PharmacoDB:HPAC_564_2019,
PRIDE:PXD003198,
PRIDE:PXD032263,
PRIDE:PXD030304,
Progenetix:CVCL_3517,
PubChem_Cell_line:CVCL_3517,
Wikidata:Q54890226 |
|
|
CVCL_3517 |
2025-01-31 12:19:18 |
30 |
HOP-92
Resource Report
Resource Website
1+ mentions
|
(RRID:CVCL_1286)
|
|
|
Omics: Transcriptome analysis by RNAseq., Omics: Transcriptome analysis by microarray., Omics: SNP array analysis., Omics: Protein expression by reverse-phase protein arrays., Omics: Metabolome analysis., Omics: lncRNA expression profiling., Omics: Fluorescence phenotype profiling., Omics: DNA methylation analysis., Omics: Deep quantitative proteome analysis., Omics: Deep proteome analysis., Omics: Deep exome analysis., Omics: CNV analysis., Omics: Array-based CGH., Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050
PMID:10700174
PMID:15748285
PMID:17088437
PMID:18277095
PMID:19372543
PMID:20164919
PMID:22068913
PMID:22347499
PMID:22384151
PMID:22628656
PMID:22961666
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28196595
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
HOP 92, HOP.92, HOP92, Hop92, Hopkins-92 |
|
|
BTO:BTO_0004085,
EFO:EFO_0006440,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03471631,
BioSample:SAMN10989594,
cancercelllines:CVCL_1286,
Cell_Model_Passport:SIDM00134,
ChEMBL-Cells:CHEMBL3308091,
ChEMBL-Targets:CHEMBL613889,
Cosmic:687783,
Cosmic:875856,
Cosmic:897510,
Cosmic:905973,
Cosmic:974290,
Cosmic:1044247,
Cosmic:1092604,
Cosmic:1146946,
Cosmic:1175862,
Cosmic:1305345,
Cosmic:1312330,
Cosmic:1995443,
Cosmic:1998446,
Cosmic-CLP:905973,
DepMap:ACH-000825,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905973,
GEO:GSM2125,
GEO:GSM50212,
GEO:GSM50275,
GEO:GSM206508,
GEO:GSM274792,
GEO:GSM274826,
GEO:GSM434299,
GEO:GSM743451,
GEO:GSM750805,
GEO:GSM794405,
GEO:GSM799339,
GEO:GSM799402,
GEO:GSM846358,
GEO:GSM1153409,
GEO:GSM1153410,
GEO:GSM1178221,
GEO:GSM1178222,
GEO:GSM1178223,
GEO:GSM1181257,
GEO:GSM1181315,
GEO:GSM1669890,
GEO:GSM2124657,
IARC_TP53:18068,
IGRhCellID:HOP-92_02GEO,
LiGeA:CCLE_870,
NCI-DTP:HOP-92,
PharmacoDB:HOP92_562_2019,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1286,
PubChem_Cell_line:CVCL_1286,
SKY/M-FISH/CGH:2810,
Wikidata:Q54890156 |
|
|
CVCL_1286 |
2025-01-31 12:19:16 |
2 |
